NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/amy-sherman-politifact/
Sign In To follow
The savings are not yet realized, says the Congressional Budget Office, which projects a 10-year cumulative savings of $161 billion from the phased-in drug negotiation, as well as a rebate for price increases above the inflation rate.
President Trump this week said that insurers would cover the costs of testing and treatment. That's not quite true.